Maximum quantity allowed is 999
CAS RN: 229975-97-7 | Product Number: A3411
Atazanavir Sulfate

Purity: >98.0%(HPLC)
- Dimethyl (3S,8S,9S,12S)-9-Benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate Sulfate
- Methyl [(5S,8S,9S,14S)-8-Benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-11-[4-(pyridin-2-yl)benzyl]-2-oxa-4,7,11,12-tetraazahexadecan-14-yl]carbamate Sulfate
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
100MG |
₹4,600.00
|
2 | 3 |
|
500MG |
₹13,000.00
|
Contact Us | 9 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | A3411 |
Purity / Analysis Method ![]() |
>98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__3__8H__5__2N__6O__7·H__2SO__4 = 802.94 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Frozen (<0°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive,Heat Sensitive |
Packaging and Container ![]() |
100MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 229975-97-7 |
Reaxys Registry Number | 11331446 |
PubChem Substance ID | 468590285 |
MDL Number | MFCD08067748 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Specific rotation | -44.0 to -48.0 deg(C=1, H2O:MeOH=1:1) |
NMR | confirm to structure |
Pictogram |
![]() |
Signal Word | Danger |
Hazard Statements | H318 : Causes serious eye damage. |
Precautionary Statements | P280 : Wear eye protection/ face protection. P305 + P351 + P338 + P310 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor. |
RTECS# | RY8794000 |
References
- BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents
- Activities of atazanavir (BMS-232632) against a large panel of human immunodeficiency virus type 1 clinical isolates resistant to one or more approved protease inhibitors
- Atazanavir: A review of its use in the management of HIV-1 infection
- Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults (a review)
- New validated RP-HPLC method for the determination of atazanavir sulphate in bulk and dosage form
- Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.